Latest article
‘Reasonable to low’ high quality proof for diabetes remission with low-carb diets
medwireNews: A systematic review and meta-analysis shows a potential increase in the...
Investor Brings Class Go well with Over Shock Diabetes Drug Delay
Law360 (May 21, 2021, 9:35 p.m. EDT) - Biopharmaceutical company Provention Bio Inc. misled its shareholders about the upcoming approval of its type 1...